日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Extracellular Vesicular Delta-Like Ligand 3 and Subtype Transcription Factors for Small Cell Lung Cancer Diagnosis.

细胞外囊泡Delta样配体3和亚型转录因子在小细胞肺癌诊断中的应用

Li Hong, Chiang Chi-Ling, Kwak Kwang Joo, Lee Hsin-Lun, Wang Xinyu, Romano Giulia, Saviana Michela, Toft Robin, Cheng Tai-Shan, Chang Yuehshih, Hsiang Bi-Da, Liu Guan-Wan, Mo Xiaokui, Ma Yifan, Pan Junjie, Rima Xilal Y, Kim Truc Nguyen, Reategui Eduardo, Shen Chia-Ning, Chu Yeh-Shiu, Croce Carlo, Chang Peter Mu-Hsin, Yeh Yi-Chen, Carbone David P, Huang Chi-Ying F, Chiang Chi-Lu, Nana-Sinkam Patrick, Lee L James

A Prospective Exploratory Study of Functional Immunity Assessed by Pretreatment Interferon Gamma Release Assay in Relation to Different Systemic Therapies in Patients With Advanced-Stage NSCLC

一项前瞻性探索性研究,旨在评估晚期非小细胞肺癌患者接受不同全身治疗后,通过治疗前干扰素γ释放试验评估的功能性免疫之间的关系

Huang, Hsu-Ching; Chang, Han-Jhih; Chiang, Chi-Lu; Huang, Hsin-Yi; Luo, Yung-Hung; Chen, Yuh-Min; Shiao, Tsu-Hui; Chiu, Chao-Hua

A comparison of clinical guidelines, treatment characteristics and outcomes in small cell lung cancer between East Asia and Europe/North America

东亚与欧洲/北美小细胞肺癌临床指南、治疗特点和结果的比较

Chiang, Chi-Lu; Soo, Ross Andrew; Mok, Tony; Voon, Pei Jye; Thamlikitkul, Lucksamon; Cheng, Ying; Horinouchi, Hidehito; Cho, Byong Chul; Xu, Krista Lin; Ahn, Myung-Ju

Asian Subgroup Analysis of Patients in the Phase 2 DeLLphi-301 Study of Tarlatamab for Previously Treated Small Cell Lung Cancer

既往接受过治疗的小细胞肺癌患者接受 Tarlatamab 治疗的 II 期 DeLLphi-301 研究中亚洲亚组分析

Ahn, Myung-Ju; Cho, Byoung Chul; Ohashi, Kadoaki; Izumi, Hiroki; Lee, Jong-Seok; Han, Ji-Youn; Chiang, Chi-Lu; Huang, Shuang; Hamidi, Ali; Mukherjee, Sujoy; Xu, Krista Lin; Akamatsu, Hiraoki

The role of immunotherapy and chemotherapy combinations in TKI-resistant EGFR-mutant non-small cell lung cancer: insights from real-world evidence

免疫疗法和化疗联合治疗在TKI耐药的EGFR突变型非小细胞肺癌中的作用:来自真实世界证据的启示

Chen, I-Ting; Huang, Hsu-Ching; Chiang, Chi-Lu; Shen, Chia-I; Tseng, Yen-Han; Liao, Ying-Ting; Chen, Yuh-Min; Luo, Yung-Hung

BBB-penetrant tyrosine kinase inhibitor plus intracranial radiotherapy vs BBB-penetrant TKI alone in Asians with EGFR-mutated lung adenocarcinoma and brain metastases

在患有EGFR突变型肺腺癌和脑转移的亚洲患者中,BBB穿透性酪氨酸激酶抑制剂联合颅内放射治疗与单独使用BBB穿透性TKI的疗效比较

Chen, You-Cong; Lin, Chun-Fu; Chiang, Chi-Lu; Yang, Huai-Che; Wu, Hsiu-Mei; Chen, Ching-Jen; Luo, Yung-Hung; Hu, Yong-Sin; Lin, Chung-Jung; Chung, Wen-Yuh; Shiau, Cheng-Ying; Guo, Wan-Yuo; Pan, David Hung-Chi; Lee, Cheng-Chia

Real-world therapeutic strategies and survival outcomes in advanced HER2 -mutant non-small cell lung cancer

晚期 HER2 突变型非小细胞肺癌的真实世界治疗策略和生存结果

Sun, Ruei-Lin; Liao, Pei-Ya; Liao, Ying-Ting; Yeh, Yi-Chen; Chiang, Chi-Lu; Chen, Yuh-Min; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Huang, Hsu-Ching; Shen, Chia-I; Tseng, Yen-Han; Huang, Yen-Hsiang; Luo, Yung-Hung; Yang, Tsung-Ying

First-line immune checkpoint inhibitors plus chemotherapy in Taiwanese patients with extensive-stage small-cell lung cancer

一线免疫检查点抑制剂联合化疗治疗台湾广泛期小细胞肺癌患者

Liao, Ying-Ting; Sun, Ruei-Lin; Huang, Hsu-Ching; Shen, Chia-I; Tseng, Yen-Han; Luo, Yung-Hung; Chen, Yuh-Min; Chiang, Chi-Lu

Population-specific polygenic risk scores for people of Han Chinese ancestry

针对汉族人群的群体特异性多基因风险评分

Chen, Hung-Hsin; Chen, Chien-Hsiun; Hou, Ming-Chih; Fu, Yun-Ching; Li, Ling-Hui; Chou, Che-Yu; Yeh, Erh-Chan; Tsai, Ming-Fang; Chen, Chun-Houh; Yang, Hsin-Chou; Huang, Yen-Tsung; Liu, Yi-Min; Wei, Chun-Yu; Su, Jen-Ping; Lin, Wan-Jia; Wang, Elin H F; Chiang, Chi-Lu; Jiang, Jeng-Kai; Lee, I-Hui; Liang, Kung-Hao; Chen, Wei-Sheng; Tsai, Hung-Cheng; Lin, Shih-Yao; Chang, Fu-Pang; Ho, Hsiang-Ling; Yeh, Yi-Chen; Tseng, Wei-Cheng; Lin, Ming-Hwai; Chang, Hsiao-Ting; Tseng, Ling-Ming; Liang, Wen-Yih; Chen, Paul Chih-Hsueh; Hsieh, Yu-Cheng; Chen, Yi-Ming; Hsiao, Tzu-Hung; Lin, Ching-Heng; Chen, Yen-Ju; Chen, I-Chieh; Mao, Chien-Lin; Chang, Shu-Jung; Chang, Yen-Lin; Liao, Yi-Ju; Lai, Chih-Hung; Lee, Wei-Ju; Tung, Hsin; Yen, Ting-Ting; Yen, Hsin-Chien; Chen, Ming-Yao; Lin, Ying-Chin; Kao, Yung-Ta; Kao, Bi-Zhen; Lee, Jing-Er; Chung, Chi-Li; Liu, Ju-Chi; Chan, Paul; Lin, Chang-Hsien; Chen, Chia-Hsin; Wu, I-Chen; Lin, Lung-Chang; Wang, Jiunn-Wei; Shih, Shen-Liang; Hsieh, Sun-Wung; Hung, Chih-Hsing; Li, Wei-Ming; Yang, Chih-Jen; Yang, Cheng-Shin; Weng, Ru-Hui; Chen, Yu-Chi; Chang, Chun-Ping; Wu, Tai-Hsun; Lin, Yu-Chang; Sheen, Yi-Jing; Wang, Shi-Heng; Chen, Sye-Pu; Raben, Timothy; Widen, Erik; Hsu, Stephen; Hsieh, Feng-Jen; Ho, Dong-Ru; Huang, Yu-Huei; Yang, Chung-Han; Huang, Yu-Shu; Chen, Yen-Fu; Wu, Hsien-Ming; Tsai, Ping-Han; Huang, Kuan-Gen; Chien, Chih-Yen; Ho, Yi-Lwun; Wu, Ming-Shiang; Kao, Jia-Horng; Liu, Yen-Bin; Juang, Jyh-Ming Jimmy; Lin, Mao-Hsin; Lin, Yen-Hung; Lee, Ji-Yuh; Lu, Hsueh-Ju; Lu, Chieh-Hua; Feng, An-Chieh; Liu, Jhih-Syuan; Chiang, Chien-Ping; Chu, Nain-Feng; Lin, Jung-Chun; Yeh, Yi-Wei; Meng, En; Huang, Chih-Yang; Li, Chi-Cheng; Wang, Tso-Fu; Su, Kuei-Ying; Wang, Jia-Kang; Chen, Mei-Hsiu; Chen, Hua-Fen; Ma, Gwo-Chin; Chang, Ting-Yu; Chiang, Fu-Tien; Chang, Hsing-Jung; Kao, Kuo-Jang; Hung, Chen-Fang; Tsai, Ching-Yao; Chen, Po-Yueh; Tsui, Kochung; Chen, Yuan-Tsong; Kwok, Pui-Yan; Sheu, Wayne Huey-Herng; Yang, Shun-Fa; Liou, Jyh-Ming; Wang, Jaw-Yuan; Chiou, Jeng-Fong; Wu, Jer-Yuarn; Fann, Cathy S J

Immune signatures of patients with advanced non-small-cell lung cancer for efficacy prediction after immunotherapy.

晚期非小细胞肺癌患者的免疫特征用于预测免疫治疗后的疗效

Luo Yung-Hung, Shen Chia-I, Chiang Chi-Lu, Chen Yuh-Min